HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA.

Abstract
Neutrophil elicitation into tissue is an essential element of the host defense in response to various stimuli, including, tissue injury, infection, or cancer. This event has gained renewed interest with the discovery of a family of small polypeptides (less than 10 kD). The salient features of these cytokines are the presence of four cysteine amino acids (first two separated by one amino acid; C-X-C) and their ability to induce neutrophil chemotaxis and activation. Recently, our laboratories have discovered a new member of this C-X-C chemotactic cytokine supergene family, neutrophil-activating peptide, ENA-78. ENA-78 shares significant amino acid sequence homology with neutrophil activating peptide-2 (NAP-2; 53%), growth regulated oncogene/melanoma growth stimulatory activity (GRO alpha; 52%), and IL-8 (22%). In addition, ENA-78 appears to activate neutrophils through the IL-8 receptor. Since both in vitro and in vivo biological fluids may contain an array of chemotactic cytokines that may be relevant to the activation and chemotaxis of neutrophils, we have developed a highly specific and sensitive sandwich ELISA for the detection of ENA-78.
AuthorsR M Strieter, S L Kunkel, M D Burdick, P M Lincoln, A Walz
JournalImmunological investigations (Immunol Invest) Vol. 21 Issue 6 Pg. 589-96 (Oct 1992) ISSN: 0882-0139 [Print] England
PMID1428026 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • CXCL5 protein, human
  • Chemokine CXCL5
  • Chemokines, CXC
  • Cytokines
  • Interleukin-8
Topics
  • Chemokine CXCL5
  • Chemokines, CXC
  • Cytokines (analysis)
  • Enzyme-Linked Immunosorbent Assay (methods, statistics & numerical data)
  • Evaluation Studies as Topic
  • Humans
  • Interleukin-8 (analogs & derivatives, analysis, biosynthesis)
  • Neutrophils (immunology)
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: